Design and synthesis of a novel peptide for selective detection of cancer cells.

Chemical Biology & Drug Design
Krishnamoorthy RajavenkateshSathiah Thennarasu

Abstract

Using a minimalist approach, an 11-residue peptide (Peptide 1) tagged with rhodamine fluorophore was designed and synthesized for selective detection of cancer cells. Peptide 1 contains RGD and NGR motifs to bind, respectively, integrins and aminopeptidase CD13, which are over expressed in cancer cells. Surface tension measurements revealed that peptide 1 possess surface-active property owing to the overall hydrophobicity and cationic nature of the peptide. Peptide 1 displays cancer cell-selective binding at ≤5.0 µM concentrations, while peptide 2 (randomized sequence of 1) shows non-selective binding to normal and cancer cells. Fluorescence microscopy and FACS analysis demonstrated the intracellular localization of peptide 1 in three different cancer cell lines, confirming the role of RGD and NGR motifs. Cytotoxicity assay exhibited the viability of normal and cancer cells up to 100 µM concentrations of peptide 1. Steady-state fluorescence measurements disclosed the preferential interactions of the peptide 1 with anionic POPC/POPG bilayers rather than with zwitterionic POPC lipid bilayers. Circular dichroism studies showed minimal changes in the secondary structure of peptide 1 upon binding with the anionic lipid bilayers. Pep...Continue Reading

References

Jan 15, 1974·Biochemistry·P Y Chou, G D Fasman
Dec 1, 1995·International Journal of Peptide and Protein Research·S Thennarasu, R Nagaraj
Aug 17, 1999·Current Opinion in Structural Biology·H Brockman
Jul 3, 2002·Nature Reviews. Cancer·Stefan Stevanovic
Jan 17, 2003·Current Drug Targets·A B Hendrich, K Michalak
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Apr 12, 2007·Critical Reviews in Therapeutic Drug Carrier Systems·Jayant J Khandare, Tamara Minko
Jul 20, 2007·Biochemical Society Transactions·L Chen, S D Harrison
Sep 21, 2007·Molecular Pharmaceutics·Olulanu H AinaKit S Lam
Nov 16, 2007·Bioconjugate Chemistry·Helena MyrbergUlo Langel
Dec 8, 2009·Cancer Cell·Kazuki N SugaharaErkki Ruoslahti
Mar 12, 2010·Methods in Molecular Biology·Walter Pirovano, Jaap Heringa
Mar 17, 2010·The Journal of Cell Biology·Erkki RuoslahtiMichael J Sailor
Jul 27, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Pirjo Laakkonen, Kirsi Vuorinen
Feb 22, 2012·The Journal of Cell Biology·Pengfei LuZena Werb
Oct 25, 2012·Journal of Translational Medicine·Zhi Jie Li, Chi Hin Cho
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lang ChenFang Li
Nov 16, 2012·Cancer Research·Luca AlbericiErkki Ruoslahti
Oct 9, 2013·Frontiers in Microbiology·Diana GasparMiguel A R B Castanho
Feb 19, 2014·Current Medicinal Chemistry·A GautamG P S Raghava
Nov 2, 2014·The Journal of Biological Chemistry·Chang LiuFang Li
Apr 15, 2016·Bioconjugate Chemistry·Alessandra GraziadioMonica Piras
May 24, 2016·Advanced Drug Delivery Reviews·Ruiwu LiuKit S Lam
Jul 8, 2016·Science Advances·Anna KingLynda K Harris
Oct 12, 2016·Chemical & Pharmaceutical Bulletin·Toshihide Takeuchi, Shiroh Futaki
May 17, 2018·Beilstein Journal of Organic Chemistry·Eirinaios I VrettosAndreas G Tzakos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

© 2021 Meta ULC. All rights reserved